Skip to main content

Advertisement

Log in

Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut

  • Short Communication
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Purpose

Increased, non-pathological FDG uptake in myocardium, stomach and bowel is frequently observed while performing clinical positron emission tomography (PET) studies. This “physiological” increased FDG uptake is not related to (oncological) disease and is unwanted since it may interfere with correct image reading. We evaluated the role of several patient-related factors that may have an influence on this phenomenon.

Methods

One hundred and seventy-five non-diabetic patients with malignant diseases, referred to our department for routine whole-body FDG-PET, were retrospectively evaluated. Age, blood glucose levels and duration of the fasting period were recorded. FDG uptake in myocardium, bowel and stomach was visually graded.

Results

Statistical analysis showed that increased FDG uptake in myocardium, bowel and stomach was not significantly correlated to blood glucose level, age or duration of fasting. Most patients who underwent repeated PET scans (92 scans in 25 patients), showed no or minor changes in uptake in bowel and stomach on the consecutive scans, while myocardial uptake was more variable.

Conclusion

Age, fasting period and blood glucose levels did not influence physiological uptake. However, there seemed to be a patient-specific pattern for stomach and bowel uptake.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Dopichaj-Menge U, Ivancevic V, Kettner B, Munz DL. Does duration of fasting influence the intensity of non-specific bowel activity in FDG-PET? [abstract]. Eur J Nucl Med 2000;27(8):1008.

    Google Scholar 

  2. Steinmetz AP, Cronin B, Wierzbicki AS, Lumb PJ, Maisey MN. Relation-ship of myocardial 18-FDG uptake in oncologic PET imaging to plasma lipid and glucose metabolism [abstract]. Eur J Nucl Med 2000;27(8):902.

    Google Scholar 

  3. Engel H, Steinert H, Buck A, Berthold T, Huch Boni RA, von Schulthess GK. Whole-body PET: physiological and artefactual fluorodeoxyglucose accumulations. J Nucl Med 1996;37(3):441–6.

    Google Scholar 

  4. Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning potential for error in interpretation. Semin Nucl Med 1996;26(4):308–14.

    Google Scholar 

  5. Hany TF, Gharehpapagh E, Kamel EM, Buck A, Himms-Hagen J, von Schulthess K. Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med 2002;29(10):1393–8.

    Google Scholar 

  6. Barrington SF, O’Doherty MJ. Limitations of PET for imaging lymphoma. Eur J Nucl Med Mol Imaging 2003;30(Suppl 1):S117–27.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michel de Groot.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Groot, M., Meeuwis, A.P.W., Kok, P.J.M. et al. Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut. Eur J Nucl Med Mol Imaging 32, 98–101 (2005). https://doi.org/10.1007/s00259-004-1670-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-004-1670-2

Keywords

Navigation